The agency has approved a four-dose version of the drug, called Mounjaro KwikPen, which provides a month’s course of GLP-1 and GIP agonist tirzepatide. Great Britain will be the first major ...
Britain became the first major market to receive Mounjaro in the new pen, known as Kwikpen, which is capable of delivering four weekly subcutaneous shots. While Germany, Switzerland, and Poland ...